Norfloxacin Stada

Norfloxacin, the active ingredient in Norfloxacin Stada, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats bacterial infections of the urinary tract, prostate, gastrointestinal tract and certain sexually transmitted infections in adult patients.

GNH USA supplies Norfloxacin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice standards and provides regulatory‑compliant shipments to a global network of healthcare providers.

Norfloxacin is a fluoroquinolone antibiotic indicated for infections of the urinary, genitourinary and gastrointestinal systems. - Uncomplicated urinary tract infection: eradicates susceptible bacteria in the bladder and urethra, relieving symptoms and preventing recurrence. - Acute prostatitis: achieves bacterial clearance within prostatic tissue, improving pain and urinary function. - Traveler’s diarrhea (gastrointestinal infection): reduces pathogen load, shortening duration of diarrheal illness. - Gonorrhea: eliminates Neisseria gonorrhoeae strains, aiding clinical cure and reducing transmission risk.

Norfloxacin may cause a range of adverse reactions, from mild to severe, that clinicians monitor during therapy.

Common Side Effects: - Nausea: mild stomach upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon injury, especially in the Achilles. - QT interval prolongation: potential cardiac arrhythmia risk. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Clostridioides difficile colitis: severe intestinal infection. - Central nervous system effects: seizures or confusion.

Before prescribing Norfloxacin, clinicians should evaluate patient‑specific factors and follow safety guidelines. - Renal impairment: assess kidney function and adjust therapy as needed. - History of tendon disorders: avoid use due to increased risk of tendon rupture. - Concomitant use with antacids or supplements containing magnesium or aluminum: separate dosing by at least two hours to ensure absorption. - Pregnancy: safety not established; use only if benefits outweigh potential risks. - Photosensitivity: advise patients to limit sun exposure and use protective clothing. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Norfloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect may lead to bleeding. - Co‑administration with other fluoroquinolones: additive toxicity without therapeutic benefit. - NSAIDs (e.g., ibuprofen): heightened risk of central nervous system stimulation and seizures.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: reduce Norfloxacin absorption; separate dosing. - Corticosteroids: may increase risk of tendon rupture. - Theophylline: Norfloxacin can raise plasma theophylline levels, requiring monitoring.